The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
Open accessAbstract
BACKGROUND: Niemann-Pick type C (NPC) disease is a fatal neurodegenerative disorder caused most commonly by a defect in the NPC1 protein and characterized by widespread intracellular accumulation of unesterified cholesterol and glycosphingolipids (GSLs). While current treatment therapies are limited, a few drugs tested in Npc1(-/-) mice have shown partial benefit. During a combination treatment trial using two such compounds, N-butyldeoxynojirimycin (NB-DNJ) and allopregnanolone, we noted increased lifespan for Npc1(-/-) mice receiving only 2-hydroxypropyl-beta-cyclodextrin (CD), the vehicle for allopregnanolone. This finding suggested that administration of CD alone, but with greater frequency, might provide additional benefit. METHODOLOGY/PRINCIPAL FINDINGS: Administration of CD to Npc1(-/-) mice beginning at either P7 or P21 and continuing every other day delayed clinical onset, reduced intraneuronal cholesterol and GSL storage as well as free sphingosine accumulation, reduced markers of neurodegeneration, and led to longer survival than any previous treatment regime. We reasoned that other lysosomal diseases characterized by cholesterol and GSL accumulation, including NPC disease due to NPC2 deficiency, GM1 gangliosidosis and mucopolysaccharidosis (MPS) type IIIA, might likewise benefit from CD treatment. Treated Npc2(-/-) mice showed benefits similar to NPC1 disease, however, mice with GM1 gangliosidosis or MPS IIIA failed to show reduction in storage. CONCLUSIONS/SIGNIFICANCE: Treatment with CD delayed clinical disease onset, reduced intraneuronal storage and secondary markers of neurodegeneration, and significantly increased lifespan of both Npc1(-/-) and Npc2(-/-) mice. In contrast, CD failed to ameliorate cholesterol or glycosphingolipid storage in GM1 gangliosidosis and MPS IIIA disease. Understanding the mechanism(s) by which CD leads to reduced neuronal storage may provide important new opportunities for treatment of NPC and related neurodegenerative diseases characterized by cholesterol dyshomeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zidovetzki, R., & Levitan, I. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.026 · Cited by 1,108
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Lloyd-Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence, D. J., Churchill, G. C., Schuchman, E. H., Galione, A., & Platt, F. M. (2008) · Nature Medicine · doi:10.1038/nm.1876 · Cited by 829
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Identification of HE1 as the Second Gene of Niemann-Pick C Disease
Naureckiene, S., Sleat, D. E., Lackland, H., Fensom, A., Vanier, M. T., Wattiaux, R., Jadot, M., & Lobel, P. (2000) · Science · doi:10.1126/science.290.5500.2298 · Cited by 824
Self-citationMurine Model of Niemann-Pick C Disease: Mutation in a Cholesterol Homeostasis Gene
Loftus, S. K., Morris, J. A., Carstea, E. D., Gu, J. Z., Cummings, C., Brown, A., Ellison, J., Ohno, K., Rosenfeld, M. A., Tagle, D. A., et al. (1997) · Science · doi:10.1126/science.277.5323.232 · Cited by 801
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
Gould, S., & Scott, R. C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.03.007 · Cited by 746
Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Patterson, M. C., Vecchio, D., Prady, H., Abel, L., & Wraith, J. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70194-1 · Cited by 608
Infante, R. E., Wang, M. L., Radhakrishnan, A., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807328105 · Cited by 491
A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.
Pentchev, P. G., Comly, M. E., Kruth, H. S., Vanier, M. T., Wenger, D. A., Patel, S., & Brady, R. O. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8247 · Cited by 397
Self-citationNiemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone
Griffin, L. D., Gong, W., Verot, L., & Mellon, S. H. (2004) · Nature Medicine · doi:10.1038/nm1073 · Cited by 395
Liu, B., Turley, S. D., Burns, D. K., Miller, A. M., Repa, J. J., & Dietschy, J. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810895106 · Cited by 377
Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport
Sleat, D. E., Wiseman, J. A., El-Banna, M., Price, S. M., Verot, L., Shen, M. M., Tint, G. S., Vanier, M. T., Walkley, S. U., & Lobel, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308456101 · Cited by 365
Self-citationJeyakumar, M. (2003) · Brain · doi:10.1093/brain/awg089 · Cited by 352
Critical role for glycosphingolipids in Niemann-Pick disease type C
Zervas, M., Somers, K. L., Thrall, M. A., & Walkley, S. U. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00396-7 · Cited by 324
Self-citationOutsourcing in the brain: Do neurons depend on cholesterol delivery by astrocytes?
Pfrieger, F. W. (2003) · BioEssays · doi:10.1002/bies.10195 · Cited by 308
Consequences of NPC1 and NPC2 loss of function in mammalian neurons
Walkley, S. U., & Suzuki, K. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.08.011 · Cited by 274
Self-citationInfante, R. E., Abi-Mosleh, L., Radhakrishnan, A., Dale, J. D., Brown, M. S., & Goldstein, J. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707943200 · Cited by 239
Patterned Purkinje cell degeneration in mouse models of Niemann‐Pick type C disease
Sarna, J. R., Larouche, M., Marzban, H., Sillitoe, R. V., Rancourt, D. E., & Hawkes, R. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10522 · Cited by 223
Liao, G., Yao, Y., Liu, J., Yu, Z., Cheung, S., Xie, A., Liang, X., & Bi, X. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070052 · Cited by 220
Lysobisphosphatidic Acid Controls Endosomal Cholesterol Levels
Chevallier, J., Chamoun, Z., Jiang, G., Prestwich, G., Sakai, N., Matile, S., Parton, R. G., & Gruenberg, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801463200 · Cited by 220
Secondary lipid accumulation in lysosomal disease
Walkley, S. U., & Vanier, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.014 · Cited by 217
Self-citationFujita, N. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.711 · Cited by 217
Ko, D. C., Binkley, J., Sidow, A., & Scott, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530027100 · Cited by 206
Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease
Camargo, F., Erickson, R. P., Garver, W. S., Hossain, G. S., Carbone, P. N., Heidenreich, R. A., & Blanchard, J. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01384-4 · Cited by 202
Pacheco, C. D., Kunkel, R., & Lieberman, A. P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm100 · Cited by 201
McGlynn, R., Dobrenis, K., & Walkley, S. U. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20355 · Cited by 200
Self-citationOhgami, N., Ko, D. C., Thomas, M., Scott, M. P., Chang, C. C. Y., & Chang, T.-Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405255101 · Cited by 200
Secondary accumulation of gangliosides in lysosomal storage disorders
WALKLEY, S. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.03.002 · Cited by 189
Self-citationA mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)
Bhaumik, M., Muller, V. J., Rozaklis, T., Linda, J., Dobrenis, K., Bhattacharyya, R., Wurzelmann, S., Finamore, P., Hopwood, J. J., Walkley, S. U., et al. (1999) · Glycobiology · doi:10.1093/glycob/9.12.1389 · Cited by 189
Self-citationCyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.
Atger, V. M., de la Llera Moya, M., Stoudt, G. W., Rodrigueza, W. V., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119223 · Cited by 176
Hahn, C. N., del Pilar Martin, M., Schroder, M., Vanier, M. T., Suzuki, K., Hara, Y., Suzuki, K., & d'Azzo, A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.205 · Cited by 173
Self-citationGenetic variations and treatments that affect the lifespan of the NPC1 mouse
Liu, B., Li, H., Repa, J. J., Turley, S. D., & Dietschy, J. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700525-jlr200 · Cited by 160
Neuropathology of the Mcoln1−/− Knockout Mouse Model of Mucolipidosis Type IV
Micsenyi, M. C., Dobrenis, K., Stephney, G. W., Pickel, J. M., Vanier, M. T., Slaugenhaupt, S. A., & Walkley, S. U. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181942cf0 · Cited by 107
Self-citationliu, Y. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.7.1087 · Cited by 103
Astrocyte‐only Npc1 reduces neuronal cholesterol and triples life span of Npc1–/– mice
Zhang, M., Strnatka, D., Donohue, C., Hallows, J. L., Vincent, I. J., & Erickson, R. P. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21730 · Cited by 93
Cholesterol Accumulation in NPC1-Deficient Neurons Is Ganglioside Dependent
Gondré‐Lewis, M. C., McGlynn, R. H., & Walkley, S. U. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00531-1 · Cited by 83
Self-citationOpen field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice
Lau, A. A., Crawley, A. C., Hopwood, J. J., & Hemsley, K. M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.024 · Cited by 81
Rodriguez‐Lafrasse, C., Rousson, R., Pentchev, P. G., Louisot, P., & Vanier, M. T. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)90021-3 · Cited by 80
Self-citationSubstrate reduction therapy for glycosphingolipid storage disorders
Lachmann, R., & Platt, F. M. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.3.455 · Cited by 80
Brain cholesterol metabolism and neurologic disease
Benarroch, E. E. (2008) · Neurology · doi:10.1212/01.wnl.0000333215.93440.36 · Cited by 68
Goldin, E., Roff, C. F., Miller, S. P. F., Rodriguez‐Lafrasse, C., Vanier, M. T., Brady, R. O., & Pentchev, P. G. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90236-o · Cited by 68
Self-citationLoss of membrane cholesterol influences lysosomal permeability to potassium ions and protons
Deng, D., Jiang, N., Hao, S.-J., Sun, H., & Zhang, G. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.018 · Cited by 63
Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome
Walkley, S. U. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00202.x · Cited by 57
Self-citationDynamics of lysosomal cholesterol in Niemann-Pick type C and normal human fibroblasts
Lange, Y., Ye, J., Rigney, M., & Steck, T. L. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30161-9 · Cited by 54
Jeulin, H., Venard, V., Carapito, D., Finance, C., & Kedzierewicz, F. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2008.12.006 · Cited by 38
Cited by
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222
Self-citationPlatt, F. M., d’Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0025-4 · Cited by 1,052
Neufeld, E. F. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001353 · Cited by 900
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
Platt, F. M., Boland, B., & van der Spoel, A. C. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208152 · Cited by 689
Metadata
- Authors
- Davidson, C. D., Ali, N. F., Micsenyi, M. C., Stephney, G., Renault, S., Dobrenis, K., Ory, D. S., Vanier, M. T., & Walkley, S. U.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-11
- Volume
- 4
- Issue
- 9
- Pages
- e6951
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2147612731
- Cited by
- 449
- References
- 46
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.